H1
PrivateLast Round
Series D
May 28, 2026
Est. Valuation
$773M
Total Funding Raised
$250.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
H1 is a healthcare technology company that provides an AI-driven platform for identifying and engaging healthcare professionals, organizations, and clinical research data.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Clinical Trials, Business Intelligence, Vertical SaaS, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
H1 Comparables
Compare H1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Norstella | 83% | |
| Komodo Health | 82% | |
| Valsoft Corporation | 81% | |
H1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 28, 2026 | ||||
| Series C Extension | Jun 9, 2022 | ||||
| Series C | Nov 16, 2021 | ||||
| Series B | Dec 17, 2020 | ||||
| Series A | Apr 22, 2020 | ||||
Accelerator | Jan 1, 2020 |
H1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dRx Capital | Series C |
| Lux Capital | Series C, Series B |
| Lead Edge Capital | Series C, Series B |
| ClearPoint Investment Partners | Series A |
| Y Combinator | Series C, Series A, Series B, Accelerator |
| Underscore VC | Series A |
| CVS Health Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2026
$40M round led by CVS Health Ventures.
- Jun 9, 2022
$33M round with participation from Menlo Ventures and Novartis.
H1 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about H1's valuation, stock price, and market status.